Alembic Pharma Wins USFDA Approval for Dapagliflozin Tablets Kumar Jeetendra | April 7, 2026 Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Dapagliflozin Tablets, 5 mg and 10 mg. Alembic Pharmaceuticals Limited Gets USFDA Approval for Dapagliflozin Tablets The approved ANDA is therapeutically equivalent to the reference listed drug product …
How BA/BE Studies Shape the Future of Generic Medicines Kumar Jeetendra | June 24, 2026 Generic medicines have become a cornerstone in healthcare as they allow healthcare systems to provide more affordable and accessible healthcare. Generic medicines must undergo significant scientific evaluations to ensure that they are as safe, high-quality, and therapeutically effective as the branded medications. Bioavailability (BA) and Bioequivalence (BE) studies are a key component in this scientific …
